As we welcome the new year, it is time to reflect on some of the most significant legal developments in the drug and device space in 2025.
1. Navigating a New Skepticism in Science
Not long ago, the average American likely could not name the U.S. secretary of health and human services. Yet, following this year’s change in administration and major shakeup in the regulatory landscape, skepticism in science has become the elephant in the room for anyone working in the drug and device sphere. Practitioners should start thinking about how to present scientific evidence to juries in 2026 as the old norms may no longer apply.
Read the full article on the Faegre Drinker website.
The material contained in this communication is informational, general in nature and does not constitute legal advice. The material contained in this communication should not be relied upon or used without consulting a lawyer to consider your specific circumstances. This communication was published on the date specified and may not include any changes in the topics, laws, rules or regulations covered. Receipt of this communication does not establish an attorney-client relationship. In some jurisdictions, this communication may be considered attorney advertising.
About the Author: Christine R. M. Kain
As a member of Faegre Drinker’s nationally ranked product liability practice, Minneapolis partner Christine Kain defends pharmaceutical, medical device, food and beverage, and other manufacturers in class actions, mass torts, product liability and consumer fraud cases.
About the Author: Jim Frederick
With a sophisticated background leading litigation, Jim Frederick defends innovative life sciences companies in pharmaceutical and medical device product liability, mass tort and consumer fraud lawsuits. Jim also represents clients in commercial litigation and appellate matters. A former Assistant U.S. Attorney in the District of Maryland, Jim wields his background investigating and prosecuting civil and criminal fraud cases to inform his defense strategy for clients.
About the Author: Caroline "Cari" Wadman
Caroline provides counsel on product regulatory compliance and is focused on defending companies in complex product liability and mass tort litigation.
About the Author: Erica Abshez Moran
Erica Abshez Moran helps clients prevent, defend, manage and resolve product liability litigation. Erica has been involved in all stages of litigation, including bringing multiple cases to trial. Her experience includes case evaluation and client counseling, drafting pleadings and motions, managing pre-trial discovery, negotiating with opposing counsel, trial preparation, and second-chairing arbitrations.
